Pharming Group NV (PHGUF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Other Operating Activity | -3,420 | -11,016 | -13,208 | 0 |
| Operating Cash Flow | $-3,420 | $-11,016 | $-13,208 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -205 | 320 | 139 | N/A |
| Net Acquisitions | -665 | N/A | N/A | N/A |
| Investing Cash Flow | $-869 | $320 | $139 | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 21,283 | 10,289 | N/A |
| Debt Repayment | N/A | -6,304 | N/A | N/A |
| Common Stock Issued | 25,755 | 16,176 | 6,868 | N/A |
| Other Financing Activity | -1,833 | -3,143 | -2,275 | 0 |
| Financing Cash Flow | $23,922 | $28,013 | $14,882 | $N/A |
| Exchange Rate Effect | 617 | -264 | -206 | N/A |
| Beginning Cash Position | 25,459 | 8,387 | 6,514 | N/A |
| End Cash Position | 45,708 | 25,440 | 8,120 | N/A |
| Net Cash Flow | $20,249 | $17,053 | $1,606 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -3,420 | -11,016 | -13,208 | N/A |
| Capital Expenditure | -205 | -28 | -790 | N/A |
| Free Cash Flow | -3,625 | -11,044 | -13,998 | 0 |